Medical and Science
APPA announces 2020 executive committee

The Australian Pharmaceutical medical and scientific Professionals Association (APPA) is pleased to announce the recently elected Executive Committee Members for 2020.
APPA is the representative association for Medical Affairs in Australia and is dedicated to promoting excellence in pharmaceutical medicine through professional development, networking and advocacy.
The association encompasses medical directors, medical advisors and medical scientific liaisons working within medical affairs departments of Australian pharmaceutical companies.
Dr. Gisela Mautner (current Vice President of APPA) was elected as the new President for 2020.
“My vision is to continue to build on our achievements of the last few years but also start new collaborations and partnerships to increase APPA’s visibility and its relevance in shaping Medical Affairs.” said Dr Mautner.
APPA Executive Committee Members for 2020
President: Dr. Gisela Mautner
Past President: Dr. Paul Theron – Merck Group
Vice President: Matthew Britland – AstraZeneca
Treasurer: Dr. Martin Rees – Stallergenes Greer
Secretary: Dr. David Grolman – Pfizer
Ordinary Members:
- Lauren Kennedy – AbbVie
- Bevan Sweerts – Sanofi Genzyme
- Mauricio Andrade – Pfizer
Register FREE to receive the latest news, innovations and insights from Health Industry Hub; the only one-stop-hub connecting Australia’s Pharma, MedTech and Biotech industry professionals and its key stakeholders.
News & Trends - MedTech & Diagnostics

Government’s claim of progress in genomics falls flat while it fails to uphold the fundamental rights of Aussies
The government has unveiled Cancer Australia’s National Framework for Genomics in Cancer Control, a strategic plan designed to guide healthcare […]
MoreNews & Trends - Pharmaceuticals

Healthcare sector’s political donations: What to expect ahead of the federal election
Ahead of the upcoming federal election, attention turns to the financial contributions to major political parties. The Australian Electoral Commission’s […]
MoreNews & Trends - Pharmaceuticals

‘Underinvestment in gynae cancer has left critical gaps,’ says ANZGOG Chair
Ovarian cancer is the deadliest women’s cancer, with the latest statistics revealing a five-year survival rate of just 49%. Alarmingly, […]
MoreNews & Trends - MedTech & Diagnostics

Labor’s one-off funding a band aid for public hospitals while private sector left in limbo
The Federal Government has committed a one-off funding boost of $1.7 billion to public hospitals under a one-year extension to […]
More